Indiana is currently home to 1224 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Indianapolis, South Bend, Fort Wayne and Evansville. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Post-Market Feasibility Study of the Tenon Medical CATAMARAN™ SI Joint Fusion System
NCT05633888
Recruiting
The purpose of this study is to evaluate the outcomes of patients with sacroiliac joint pain treated with the CATAMARAN SI Joint Fusion System.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
03/18/2024
Locations: Comprehensive Pain and Spine Specialists, Muncie, Indiana
Conditions: Sacroiliac Joint Disruption, Degenerative Sacroiliitis
Register for Updates
CorMatrix Cor TRICUSPID ECM Valve Replacement - Pivotal Study
NCT05742906
Recruiting
The goal of this pivotal study is to demonstrate the safety and performance of the Cor TRICUSPID ECM (extracellular matrix) Valve (or Cor PEDIATRIC Tricuspid ECM Valve) for the surgical management of tricuspid valve disease and dysfunction in adult and pediatric patients. The main question(s) it aims to answer are: * whether the device may be implanted successfully and safely, and * whether the device effectively treats tricuspid valve disease and dysfunction through 12 months Participants wil... Read More
Gender:
ALL
Ages:
All
Trial Updated:
03/14/2024
Locations: St Francis Hospital, Indianapolis, Indiana
Conditions: Tricuspid Valve Disease, Tricuspid Valve Insufficiency
Register for Updates
Hemlibra in Mild Hemophilia A
NCT04567511
Recruiting
This is a single arm, phase 4, prospective, open-label, United States single-center study to determine the hemostatic characteristics of Hemlibra (emicizumab) as measured by coagulation laboratory parameters in the mild hemophilia A male patient population with endogenous altered FVIII (baseline FVIII activity of \>5% to 30%). The safety and hemostatic efficacy of Hemlibra (emicizumab) in this patient population will be investigated. Secondary outcomes will assess changes in joint health and qua... Read More
Gender:
MALE
Ages:
Between 5 years and 45 years
Trial Updated:
03/13/2024
Locations: Indiana Hemophila @Thrombosis Center, Indianapolis, Indiana
Conditions: Factor VIII Deficiency, Congenital
Register for Updates
LOWER: Lomitapide Observational Worldwide Evaluation Registry
NCT02135705
Recruiting
This global product exposure registry is a multicentre, long-term, prospective, observational cohort study (exposure registry), designed to evaluate the long term safety and effectiveness of lomitapide.
Gender:
ALL
Ages:
All
Trial Updated:
03/11/2024
Locations: Community Health Network, Indianapolis, Indiana
Conditions: Homozygous Familial Hypercholesterolemia
Register for Updates
Prospective SPINE Registry
NCT04176562
Recruiting
This study is a prospective, multi-center, open label registry designed to collect real-world data on performance and safety data on RTI's spine products.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/08/2024
Locations: Indiana Spine Group, Carmel, Indiana
Conditions: Sacroiliac; Fusion, Sacroiliac, Joint Diseases, Musculoskeletal Diseases, Spinal Disease, Spinal Stenosis, Spinal Instability, Fusion of Joint, Fusion of Spine, Spinal Fusion, Spine
Register for Updates
Alzheimer's Disease Genetics Study
NCT00064870
Recruiting
The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset AD can be investigated is by identifying and collecting genetic material from families with multiple members diagnosed with AD or dementia.
Gender:
ALL
Ages:
All
Trial Updated:
03/07/2024
Locations: Participants are being recruited from all over the United States, Multiple Locations, Indiana
Conditions: Alzheimer Disease, Late Onset Alzheimer Disease, Dementia
Register for Updates
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
NCT06309160
Recruiting
Purpose: The purpose of this project is to develop and test the COMPASS \[Collaborative Model for Competence and Success\] Across Settings (CAST) intervention to enhance the goal setting and attainment skills of autistic youth. Despite federal education law mandating transition services as part of the Individualized Education Program (IEP) for ensuring good outcomes for students with disabilities, current educational practices have been unable to demonstrate that autistic students experience pos... Read More
Gender:
ALL
Ages:
Between 16 years and 99 years
Trial Updated:
03/06/2024
Locations: Ball State University, Muncie, Indiana
Conditions: Autism, Autism Spectrum Disorder, Autistic Disorder
Register for Updates
CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting
NCT05002543
Recruiting
MANTRA is a prospective, multiple-arm, multi-center, global, post-market clinical follow-up study. The main objective is to monitor ongoing safety and performance of the CORCYM devices and accessories used for aortic, mitral and tricuspid valvular diseases in a real-world setting. Corcym S.r.l., is a medical device manufacturer with a broad product portfolio for cardiac surgeons, offering solutions for the treatment of aortic, mitral and tricuspid valve disease. The MANTRA Master Plan (Master... Read More
Gender:
ALL
Ages:
All
Trial Updated:
03/05/2024
Locations: St. Vincent Heart Center of Indiana, Indianapolis, Indiana
Conditions: Cardiac Valve Disease
Register for Updates
Molecular Mechanisms Associated With Breast Implant Complications
NCT05736354
Recruiting
Bacterial biofilms cause implant failures, chronic inflammation, and immune polarization. The study investigates the possible role of bacterial biofilm as a factor in the etiology of Breast Implant Illness. Three patient cohorts will be studied (A) Subjects with breast implant with BII manifestations (B) Subjects with breast implants without BII manifestations (C) Subjects without breast implants who underwent breast surgery procedure. Blood, surgically discarded tissue, implants, and associated... Read More
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
03/04/2024
Locations: IU Health North Hospital, Carmel, Indiana
Conditions: Breast Implant; Complications, Infection or Inflammation
Register for Updates
Dissemination and Implementation of Improving Pediatric Obesity Practice Using Prompts
NCT05627011
Recruiting
The purpose of this study is to evaluate the dissemination and implementation of electronic health record-based clinical decision support tools for the management of pediatric overweight and obesity in primary care.
Gender:
ALL
Ages:
2 years and above
Trial Updated:
02/27/2024
Locations: Eskenazi Health, Indianapolis, Indiana
Conditions: Obesity, Childhood
Register for Updates
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
NCT01574053
Recruiting
Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and Australasia-while also expanding to include sites in Latin America. More than 30,000 participants have now enrolled into the study. With annual assessments and no end date, Enroll-HD has built a large and rich database of longitudinal clinical data and biospecimens that form the basis for studies developing tools and b... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/26/2024
Locations: Indiana University, Indianapolis, Indiana
Conditions: Huntington's Disease
Register for Updates
Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis Patients
NCT06250309
Recruiting
This is a single-center, proof-of-concept pilot study which uses a cross-over design to compare two dietary interventions/treatments: Western Diet (WD) vs Mediterranean (MD) and impact on quality-of-life parameters in AIH. Participants will receive both treatments through two phases and will be divided into two groups.
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
02/19/2024
Locations: IU Health University Hosptial, Indianapolis, Indiana
Conditions: Autoimmune Hepatitis
Register for Updates